| Authors: |
Lukic T; Pfizer Inc, New York, NY, USA., Ghosh P; Pfizer Inc, Cambridge, MA, USA., Napatalung L; Pfizer Inc, New York, NY, USA.; Mount Sinai Hospital, New York, NY, USA., Wang C; Pfizer Inc, Groton, CT, USA., Kurosky SK; Pfizer Inc, New York, NY, USA., Hamzavi I; Henry Ford Health, Detroit, MI, USA., Sinclair R; University of Melbourne, Melbourne, VIC, Australia.; Sinclair Dermatology, East Melbourne, VIC, Australia., Xiang L; Huashan Hospital, Fudan University, Shanghai, China., Steil K; CCT Research, Scottsdale, AZ, USA.; University of Arizona, Phoenix, AZ, USA., Rosmarin D; Indiana University School of Medicine, Indianapolis, IN, USA., Parsad D; Postgraduate Institute of Medical Education and Research, Chandigarh, India., Ezzedine K; Université Paris-Est Créteil, Créteil, France.; Henri-Mondor University Hospital, Créteil, France., Adiri R; Pfizer Pharmaceutical Israel Ltd, Arye Shenkar St 9, 4672509, Herzliya, Israel. Roni.Adiri@pfizer.com. |